Published • loading... • Updated
Man sees deadly brain tumour shrink by half thanks to new radioactive therapy
- A man has seen his deadly brain tumour shrink by half thanks to a new radioactive therapy, which experts hope will eradicate the disease.
- Paul Read, a 62-year-old engineer from Luton, is the first patient to take part in the trial and has seen his tumour shrink in half in a matter of weeks.
- Dr. Paul Mulholland, UCLH consultant medical oncologist who designed the trial, said the reduction of Mr. Read's tumour 'is really quite remarkable for somebody whose tumour is so aggressive.'
- Researchers plan to combine ATT001 with immunotherapy, which trains the body's immune system to kill cancerous cells.
Insights by Ground AI
16 Articles
16 Articles
New cancer treatment trial shrinks Luton man's brain tumour by half after just weeks of radioactive injections
Paul Read, a 62-year-old engineer, was the first patient to undergo an experimental trial where radiation is injected directly into his brain tumour. Doctors say it has reduced the size of the cancer by half.
·United Kingdom
Read Full Article
Man sees deadly brain tumour shrink by half thanks to new radioactive therapy – UK Times
A man has seen his deadly brain tumour shrink by half thanks to a new radioactive therapy, which experts hope will eradicate the disease. Doctors at University College London Hospitals NHS Foundation Trust (UCLH) are running a clinical trial to treat glioblastoma, a type of cancer which kills most patients within 18 months. Their aim is to cure the disease through injecting low levels of radioactivity directly into the tumour to kill off cancer …
Coverage Details
Total News Sources16
Leaning Left3Leaning Right3Center6Last UpdatedBias Distribution50% Center
Bias Distribution
- 50% of the sources are Center
50% Center
L 25%
C 50%
R 25%
Factuality
To view factuality data please Upgrade to Premium
